PTX3 and sarcopenia: Persistent immune activation and tissue remodeling characteristic of chronic inflammation drive the development of insulin resistance, diabetes progression, atherosclerosis, and sarcopenia [6,46], highlighting the potential clinical significance of PTX3 modulation through exercise as a non-pharmacological strategy to improve metabolic and vascular health.